Ephedra nevadensis (Mormon-Tea) Aerial
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ephedra nevadensis Source : Sommité | 615 milligramme | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 615 Mesures | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine as a decongestant/to relieve nasal congestion. Used in Herbal Medicine as a decongestant/to relieve nasal congestion (due to hay fever/allergic rhinitis/allergies). Used in Herbal Medicine as a decongestant/to relieve nasal congestion (due to the common cold). Used in Herbal Medicine as a decongestant/to relieve nasal congestion (due to sinusitis). Used in Herbal Medicine as a decongestant/to relieve nasal congestion (due to flu).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
May cause mild tachycardia, hypertension, insomnia, jitteriness, decreased appetite, irritability, headaches, nausea, vomiting and disturbances of urination. Insomnia has been known to occur; in which case, discontinue use. Irritability, dizziness and/or tremor have been known to occur; in which case, discontinue use. Nausea and/or loss of appetite have been known to occur; in which case, discontinue use. Rapid heartbeat has been known to occur; in which case, discontinue use. Restlessness has been known to occur; in which case, discontinue use. Severe headache has been known to occur; in which case, discontinue use. Shortness of breath, and/or disturbance of urination have been known to occur; in which case, discontinue use.
- Contre-indications
Do not exceed the recommended dose. Keep away from children. Do not use if you are pregnant or breastfeeding. Do not use if you suffer from anxiety, restlessness, high blood pressure, glaucoma, impaired circulation of the cerebrum, adenoma of the prostate with residual urine accumulation, pheochromocytoma or thyrotoxicosis. Do not use if you are taking, or have taken in the past two weeks monoamine oxidase (MAO) inhibitors.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking prescription medication, or if you have a serious medical condition. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for allergy symptoms. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for cough/cold. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for weight control. Consult a health care practitioner prior to use if you are taking other products which contain caffeine. Consult a health care practitioner prior to use if you are taking other products which contain ephedrine. Consult a health care practitioner prior to use if you are taking other products which contain phenylpropanolamine. Consult a health care practitioner prior to use if you are taking other products which contain pseudophedrine. Consult a health care practitioner prior to use if you have cardiovascular disease. Consult a health care practitioner prior to use if you have diabetes. Consult a heath care practitioner prior to use if you have difficulty in urination due to prostate enlargement. Consult a health care practitioner prior to use if you have glaucoma. Consult a health care practitioner prior to use if you have pre-existing psychiatric conditions. Consult a health care practitioner prior to use if you have seizure disorders. Consult a health care practitioner prior to use if you have thyroid problems.
Product record
- Licence holder
- 1669652 Alberta Ltd
- NPN or DIN-HM
- 80039750
- Status
- Inactive licence
- Licence date
- 12 February 2013
- Revision date
- Not provided
- Form
- Herbe sèche
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80039750
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Ephedra nevadensis (Mormon-Tea) Aerial (1669652 Alberta Ltd): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80039750-ephedra-nevadensis-mormon-tea-aerial, updated 12 February 2013.